Please login to the form below

Not currently logged in

Parexel signs drug development collaboration with Taiwanese hospital

Will work with the National Taiwan University Hospital

Parexel has formed an alliance with a leading Taiwanese hospital to provide drug development services in the country.

The deal with the National Taiwan University Hospital (NTUH) continues the contract research organisation's (CRO) expansion in Asia as it seeks to position itself to work more with both local and global biopharmaceutical companies.

Joe Avellone, corporate senior vice president of clinical research services at Parexel, said: “Partnering with National Taiwan University Hospital further enhances our ability to meet the increasing demand from our clients to provide a full scope of phase I-IV clinical trials in a rapidly growing market.

“The National Taiwan University Hospital is well-known and highly respected in Taiwan. We are pleased to have the opportunity to work together to advance our biopharmaceutical clients' programmes in the region and help them to compete more effectively in the global marketplace.”

The CRO said its latest collaboration would “drive greater efficiency” for trial sponsors and help the partners create innovative development and marketing solutions for the region.

Ming-Fong Chen, superintendent at NTUH, said: “This partnership will bring opportunities for both Parexel and NTUH to leverage our combined expertise in order to accelerate clinical development programmes in Taiwan and meet patients' need for more effective treatments.”

The deal follows two agreements in nearby South Korea. In February, Parexel joined up with Seoul's ASAN Medical Center (AMC) to expand the clinical trial services it offers throughout Asia.

Then in July, the CRO was subsequently chosen by government consortium the Korea Drug Development Fund (KDDF) to help Korean companies develop and commercialise healthcare products for the global market.

29th November 2012

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...